Search clinical trials for: pramipexole 0.25 mg BID
Total 969 results
-
Dr. Reddy's Laboratories LimitedXenoPort, Inc.Completed
-
Institute of Medical Biology, Chinese Academy of...Hebei Provincial Center for Diseases Control and PreventionCompleted
-
RFS Pharma, LLCWithdrawnHuman Immunodeficiency Virus Infection
-
Suzhou Kintor Pharmaceutical Inc,Suzhou Koshine Biomedica, Inc.Active, not recruiting
-
Merck Sharp & Dohme LLCCompleted
-
PfizerCompletedDermatitis, AtopicAustralia, United States
-
PfizerCompleted
-
Gangnam Severance HospitalCompleted
-
Institute of Hematology & Blood Diseases HospitalNot yet recruitingThe Prophylactic Value of Ruxolitinib for aGVHD in HSCT Recipients of AA
-
PfizerTerminatedHuntington's DiseaseUnited States, Germany, Poland, United Kingdom, Canada
-
NicOxCompletedHypertension | OsteoarthritisUnited States
-
Yong-Hee ParkChung-Ang UniversityCompletedBlood Pressure | Intubation ComplicationKorea, Republic of
-
N-Gene Research Laboratories, Inc.Thermo Fisher Scientific, Inc; Integrium; Msource Medical Development GmbH; Kinexum... and other collaboratorsTerminatedDiabetes MellitusUnited States, Germany, Hungary
-
Incyte CorporationCompletedAtopic DermatitisUnited States, Canada
-
Georgetown UniversityCompletedPeripheral Vascular DiseaseUnited States
-
Endo PharmaceuticalsCompletedAdhesive Capsulitis | Frozen ShoulderUnited States
-
Emerald Health PharmaceuticalsSuspendedRelapsing Forms of Multiple SclerosisUnited States, Australia
-
Biotie Therapies Inc.CompletedParkinson's DiseaseUkraine, Argentina, Romania, Canada, United States, Chile
-
Wuhan Union Hospital, ChinaCompletedCoronary Artery Disease | Percutaneous Coronary InterventionChina
-
BiocodexRecruitingChronic Renal InsufficiencyBulgaria
-
GlaxoSmithKlineTerminated
-
Cara Therapeutics, Inc.TerminatedPruritus | Notalgia ParestheticaUnited States, Canada, Poland, Spain, Germany
-
University of the RyukyusCompletedCoronary Artery Disease | Inflammation | Diabetes Mellitus, Type 2 | Diarrhea | Colchicine | White Blood CellJapan
-
CTI BioPharmaPPDRecruiting
-
TetraLogic PharmaceuticalsPPD; The Leukemia and Lymphoma Society; Veristat, Inc.; Therapeutics, Inc.CompletedLymphoma, T-Cell, CutaneousUnited States
-
PfizerTerminatedMultiple SclerosisUnited States
-
Acer Therapeutics Inc.CompletedPost-menopausal Vasomotor SymptomsUnited States
-
ChimerixTerminatedProtein Losing EnteropathyUnited States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesChina
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedPostmenopause | Postmenopausal Osteoporosis
-
Zai Lab (Shanghai) Co., Ltd.CompletedHepatocellular Carcinoma (HCC)China
-
Eli Lilly and CompanyCompletedGlioblastoma MultiformeGermany
-
Vifor (International) Inc.FortreaCompletedSickle Cell DiseaseUnited States, France, Greece, Lebanon, United Kingdom
-
Autoimmune Technologies, LLCCompleted
-
University of OxfordMahidol Oxford Tropical Medicine Research Unit; Nangarhar UniversityCompletedVivax MalariaAfghanistan
-
Medical College of WisconsinWithdrawnRefractory Multiple Myeloma | Relapse Multiple Myeloma
-
Suzhou Zanrong Pharma LimitedRecruitingAdvanced Solid Tumors | HER2-positive Breast CancerChina
-
ShireCompletedCrohn's DiseaseUnited States, Canada
-
Yuhan CorporationTerminatedFunctional DyspepsiaKorea, Republic of
-
Bial R&D Investments, S.A.RecruitingParkinson's DiseaseUnited States, Spain, France, Italy, Netherlands, United Kingdom, Germany, Canada, Poland, Portugal, Sweden
-
Merck Sharp & Dohme LLCTerminated
-
Merck Sharp & Dohme LLCCompleted
-
University of California, DavisCompletedSurgeryUnited States
-
Bial - Portela C S.A.Completed
-
vTv TherapeuticsNot yet recruitingDiabetes Mellitus, Type 1
-
Eisai Inc.CompletedObesityUnited States
-
QED Therapeutics, Inc.Enrolling by invitationAchondroplasiaAustralia, United States, Argentina, Canada, France, Germany, Italy, Norway, Singapore, Spain, United Kingdom
-
Cara Therapeutics, Inc.Completed
-
Foresee Pharmaceuticals Co., Ltd.TerminatedSevere to Critical COVID 19 With Associated ARDSUnited States